MRI Interventions to Exhibit its Clearpoint® Neuro Navigation System for SNO/SCIDOT Joint Conference on Therapeutic Delivery to the CNS

IRVINE, Calif., – MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint Neuro Navigation System will be at the Society for Neuro-Oncology (SNO) and the Society for CNS Interstitial Delivery of Therapeutics (SCIDOT) Joint Conference on Therapeutic Delivery to the CNS - November 18th and 19th, 2015, in San Antonio, TX. Attendees are invited to visit the MRI Interventions exhibit to learn about the use of the ClearPoint Neuro Navigation System for monitoring convection enhanced drug delivery (CED).

"The ClearPoint Neuro Navigation System provides MRI guidance and placement of catheters for drug infusion into the brain allowing clinicians to directly monitor distribution of therapeutics under real-time, MRI visualization. Any reflux along the CED catheter or leakage outside the target area, can be visualized and corrective steps taken and confirmed almost immediately." said, Krystof Bankiewicz, M.D., Ph.D., Professor of Neurosurgery and Neurology, Kinetics Foundation Chair in Translational Research, University of California San Francisco.

The ClearPoint neuro navigation system allows surgeons to plan, target, and adjust trajectories under real time MRI-guided visualization for placement of electrodes, catheters and biopsy needles.

About MRI Interventions, Inc.

Building on the imaging power of MRI, MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart. The ClearPoint system, which has received 510(k) clearance and is CE marked, utilizes a hospital's existing diagnostic or intraoperative MRI suite to enable a range of minimally invasive procedures in the brain. For more information, please visit


Wendelin Maners, VP, Marketing

MRI Interventions, Inc.



All Topics